Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
31,49 USD | +4,69 % | +6,21 % | -6,67 % |
08/05 | PACIRA BIOSCIENCES, INC. : Needham & Co. maintient sa recommandation à l'achat | ZM |
07/05 | Transcript : Pacira BioSciences, Inc., Q1 2024 Earnings Call, May 07, 2024 |
Métier
Nombre d'employés: 712
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Non-opioid Pain Management and Regenerative Health Solutions
100,0
%
| 667 | 100,0 % | 675 | 100,0 % | +1,22 % |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 667 | 100,0 % | 675 | 100,0 % | +1,22 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Frank Lee
CEO | Chief Executive Officer | 56 | 02/01 |
Charles Reinhart
DFI | Director of Finance/CFO | 63 | 01/11/11 |
Jonathan Slonin
CTO | Chief Tech/Sci/R&D Officer | 49 | 01/07/21 |
Anthony Molloy
CMP | Compliance Officer | 50 | - |
Kristen Williams
ADM | Chief Administrative Officer | 50 | 01/12/11 |
Daryl Gaugler
COO | Chief Operating Officer | 62 | 01/06/19 |
Susan Mesco
IRC | Investor Relations Contact | - | 01/04/15 |
Max Reinhardt
PRN | Corporate Officer/Principal | 53 | 19/06/19 |
Corporate Officer/Principal | 52 | 19/04/23 | |
Lauren Riker
PRN | Corporate Officer/Principal | 45 | 21/03/12 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Gary Pace
BRD | Director/Board Member | 76 | 01/06/08 |
Paul Hastings
CHM | Chairman | 64 | 02/06/11 |
Andreas Wicki
BRD | Director/Board Member | 64 | 01/12/06 |
Laura Brege
BRD | Director/Board Member | 66 | 02/06/11 |
Mark Kronenfeld
BRD | Director/Board Member | 69 | 12/06/13 |
Alethia Young
BRD | Director/Board Member | 45 | 10/10/23 |
Marcelo Bigal
BRD | Director/Board Member | - | 10/10/23 |
Mark Froimson
BRD | Director/Board Member | 63 | 15/06/17 |
Frank Lee
CEO | Chief Executive Officer | 56 | 02/01 |
Director/Board Member | 61 | 18/09/19 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 46 546 148 | 45 958 599 ( 98,74 %) | 0 | 98,74 % |
Coordonnées société
Pacira Biosciences, Inc.
5401 West Kennedy Boulevard Suite 890
33609, Tampa
+813 553 6680
http://www.pacira.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-6,67 % | 1,4 Md | |
+32,36 % | 709 Md | |
+30,77 % | 595 Md | |
-1,60 % | 367 Md | |
+20,07 % | 334 Md | |
+6,04 % | 289 Md | |
+14,77 % | 239 Md | |
+9,13 % | 211 Md | |
-3,97 % | 203 Md | |
+9,27 % | 171 Md |
- Bourse
- Actions
- Action PCRX
- Société Pacira BioSciences, Inc.